Biophytis extends cash runway to Q1 2027 after EUR 2.5 million warrant exercise
BPTS•Cash runway extended after balance-sheet restructuring
Biophytis pushed its cash runway to Q1 2027 following a balance-sheet restructuring.
Cash position reached EUR 3 million as of Aug. 31, 2026, supported by EUR 3.7 million gross inflows.
Most BSA 2026 warrants were exercised, generating EUR 2.5 million of proceeds at an exercise price of EUR 0.04.
Financial debt fell to EUR 2.9 million from EUR 4.27 million, driven by EUR 1.37 million of debt converted into equity.
Shares outstanding rose to about 240 million as of Aug. 31, 2026, reflecting warrant exercises and debt-for-equity conversions.
